Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022
Author:
Affiliation:
1. School of Medicine, New York Medical College, Valhalla
2. Department of Oncology, Geneva University Hospital, Geneva, Switzerland
3. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2793228/mousavi_2022_oi_220467_1654263497.52435.pdf
Reference21 articles.
1. National health expenditure projections, 2018-27: economic and demographic trends drive spending and enrollment growth.;Sisko;Health Aff (Millwood),2019
2. The high price of anticancer drugs: origins, implications, barriers, solutions.;Prasad;Nat Rev Clin Oncol,2017
3. Prices and clinical benefit of cancer drugs in the USA and Europe: a cost-benefit analysis.;Vokinger;Lancet Oncol,2020
4. The correlation between clinical benefit and financial cost of cancer drugs.;Mitchell;J Clin Oncol,2020
5. Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival: an analysis of 5 years of US Food and Drug Administration approvals.;Kim;JAMA Intern Med,2015
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adjuvant anti-PD1 immunotherapy of resected skin melanoma: an example of non-personalized medicine with no overall survival benefit;Critical Reviews in Oncology/Hematology;2024-10
2. CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harms;European Journal of Cancer;2024-08
3. Postrecurrence Treatment in Neoadjuvant or Adjuvant FDA Registration Trials;JAMA Oncology;2024-08-01
4. Sustainability: a multifaceted important aspect of cancer care;BJC Reports;2024-03-08
5. Adjuvant therapy for stage IIB + IIC melanoma;Journal of Surgical Oncology;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3